Skip to main contentSkip to navigation
Sirius Investors
Invitae Corporation

Invitae Corporation

NVTA
NYSEHealthcare

Revenue Analysis - NVTA

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

NVTA Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Diagnostic Tests

0.0% of total revenue

$117.6M

Oncology

0.0% of total revenue

$61.7M

Women's Health

0.0% of total revenue

$26.9M

Rare Diseases

0.0% of total revenue

$23.3M

Collaboration And Genome Network

0.0% of total revenue

$3.7M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Collaboration And Genome Network
Diagnostic Tests
Oncology
Rare Diseases
Test Revenue, Centralized
Test Revenue, Decentralized
Women's Health
9/30/2023$3.7M$117.6M$61.7M$23.3M$0$0$26.9M
6/30/2023$4.6M$115.9M$59.8M$22.0M$0$0$26.6M
3/31/2023$4.7M$112.6M$60.3M$20.1M$0$0$24.9M
12/31/2022$3.4M$119.0M$0$0$0$0$0
9/30/2022$4.7M$128.8M$0$0$117.1M$11.7M$0
6/30/2022$3.4M$133.2M$0$0$122.1M$11.1M$0

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Collaboration And Genome Network-19.8%

Geographic Regions

Declining Regions
CANADA-17.6%

Earnings Reports

Want to see how NVTA's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports